Frazier Financial Advisors’s AbbVie ABBV Stock Holding History

Frazier Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.92M	Buy	18,035 +351	+2%	+$77.9K	2.17%	11
2025 Q4	$4.04M	Sell	17,684 -224	-1%	-$51K	2.39%	9
2025 Q3	$4.15M	Hold	17,908	–	–	2.55%	9
2025 Q2	$3.32M	Sell	17,908 -77	-0.4%	-$14.3K	2.35%	12
2025 Q1	$3.77M	Sell	17,985 -400	-2%	-$77.8K	2.91%	11
2024 Q4	$3.24M	Buy	18,385 +1,250	+7%	+$230K	2.57%	11
2024 Q3	$3.38M	Buy	17,135 +30	+0.2%	+$5.6K	2.63%	9
2024 Q2	$2.93M	Buy	17,105 +88	+0.5%	+$14.6K	2.33%	10
2024 Q1	$3.1M	Sell	17,017 -1,044	-6%	-$180K	2.54%	9
2023 Q4	$2.8M	Buy	+18,061	New	+$2.63M	2.43%	9

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Frazier Financial Advisors's ABBV Position: Q1 2026 in Review

Frazier Financial Advisors increased its AbbVie (ABBV) stake by 2% in Q1 2026, buying an estimated $77.9K and bringing the position to 18,035 shares worth $3.92M. The position accounts for 2.17% of the portfolio, ranked #11.

Frazier Financial Advisors first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.15M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Frazier Financial Advisors held 18,035 shares of AbbVie worth $3.92M as of Q1 2026.
Frazier Financial Advisors bought 351 AbbVie shares in Q1 2026, an estimated $77.9K.
AbbVie made up 2.17% of Frazier Financial Advisors's portfolio in Q1 2026, its #11 holding.
Frazier Financial Advisors first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Frazier Financial Advisors's AbbVie position peaked at $4.15M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.